Clinical Trial Modernization Act

# Clinical Trial Modernization Act (HR 3521) Summary **What It Would Do** The Clinical Trial Modernization Act aims to update and improve how clinical trials—medical research studies testing new treatments—are conducted in the United States. While specific provisions aren't detailed in the available information, modernization bills of this type typically focus on streamlining the trial process, reducing administrative burdens on researchers, making it easier for patients to participate, and potentially accelerating the development of new medicines and treatments. **Who It Affects** This bill would impact pharmaceutical companies and medical device manufacturers conducting research, academic medical centers, patients eligible to participate in trials, and ultimately healthcare providers and the general public who benefit from new treatments. It could also affect regulatory agencies like the FDA that oversee clinical trials. **Current Status** As of now, HR 3521 is in committee, meaning it has been introduced but hasn't advanced to a full House vote.

The bill was sponsored by Representative Raul Ruiz (D-CA). For more detailed information about specific provisions, you can search for the bill on Congress.gov to view the full legislative text.